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Identity 
Other names: 447AA 




In 1992 the cDNA sequence of COL16A1 has been 
discovered in a screening for collagen-like sequences in 
cDNA banks of a human fibroblast cell line and human 
placenta tissue.  
Two laboratories published independently the human 
COL16A1 cDNA sequence (Pan et al., 1992; 
Yamaguchi et al., 1992).  
The coding sequence of authentic collagen type XVI 
comprises of 1604 amino acids including a 21 amino 
acid signal peptide, whereas the recombinant version of 
collagen type XVI contains 1597 amino acids (Kassner 
et al., 2004).  
The nucleotide sequences published by Pan et al. and 
Yamaguchi et al. were completed by Kassner et al. with 
respect to a missing codon for one amino acid (Kassner 
et al., 2004).  
Two predicted imperfections in the collagenous region 
could not be confirmed (unpublished data). 
Transcription 
The cDNA of 5,4 kb comprises a 4809 bp coding 
sequence, framed by non-translated parts, including a  
 
425 bp 3'-non-coding sequence which contains  
polyadenylating signals. COL16A1 has been localized 
to chromosome 1, 1p35-p34 (Pan et al., 1992).  
No splice variants have been described up to now. 
COL16A1 gene expression and transcription varies in 
various phases of cell growth in cultured skin 
fibroblasts.  
Gene expression was increased in stationary phases 
(G0/G1) of cell growth when cell proliferation was 
inhibited by serum deprivation or suspension arrest 
(Tajima et al., 2000).  
Transcription activity of the COL16A1 gene appears to 
be mechanosensitive. It is downregulated in HCS2/8 
human chondrosarcoma cells after application of 
continuous hydrostatic pressure (Sironen et al., 2002).  
Recently, COL16A1 is described to act as a Smad-
signalling specific target gene for BMP-4/BMP-6 in 
hepatocellular carcinoma (Maegdefrau and Bosserhoff, 
2012). 
Pseudogene 
No pseudogenes are described up to now. 
Protein 
Description 
Collagen type XVI, by structural analogy a member of 
the FACIT - (fibril-associated collagens with 
interrupted triple helices) family of collagens, contains 
10 collagenous (COL) domains interspersed with 11 
non-collagenous (NC) regions (figure 1A-C).  
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Figure 1. Collagen type XVI, domain and molecular structure. Collagen type XVI affinity-purified from culture medium of over 
expressing HEK 293 EBNA cells elutes in full-length chains and proteolytically processed fragments with following molecular weight as 
(213 kDa) (A), (182 kDa) (B) and (78 kDa) (C). One alpha 1 chain of intact collagen XVI consists of 10 collagenous domains (COL1-
COL10) and 11 non-collagenous domains (NC1-NC11). Atomic Force Microscopy (AFM) of affinity-purified recombinant full-length 
collagen type XVI trimers allows measurement of molecular size (D). Rotary shadowed TEM image of purified recombinant full-length 
collagen type XVI trimers corroborates the AFM data (E). Length of intact collagen XVI comes to about 240 nm. COL= collagenous 
domains, NC= non-collagenous domains. 
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It is a homotrimeric molecule of about 210 kDa for 
each native α1 chain. 32 cysteine residues, which are 
almost all located in the non-collagenous domains at 
the junction to the preceding collagenous regions, 
contribute to a high thermal stability of the homotrimer 
in form of disulfide bonds (Pan et al., 1992; Yamaguchi 
et al., 1992). The prominent non-collagenous NC11 
domain consists mainly of a 200-residue motif referred 
to as proline-arginine-rich protein (PARP) in several 
other collagen types or as tsp-1 in thrombospondin 
(figure 1A). It has been recombinantly expressed an
used for generation of specific anti-NC11 antibodies 
(Tillet et al., 1995). 24% of the total number of proline 
residues and 48% of the total number of lysine residues 
were hydroxylated in recombinant collagen type XVI.  
Because only lysine and proline in the Y position of X-
Y-Gly amino acid triplets and additionally some lysine 
residues in the Y position of X-Y-Ser and X-Y-Ala in
collagens are subject to hydroxylation, the amino acid 
sequence of authentic human collagen type XVI would 
imply that 54% of the available prolines and a 
maximum of 92% of the available lysines could 
potentially be hydroxylated in recombinant collagen 
type XVI.  
Two of the three potential N-glycosylation sites reid  
in the N-terminal NC11 region and are glycosylated.  
The third has been assigned to the NC1 domain 
whereas here, no evidence has been found for the 
attachment of a glycosaminoglycan chain (Kassner et 
al., 2004). 
Atomic force images of individual trimeric molecules 
exhibited a total length of 168 ± 3 nm including the N-
terminal NC11 globular domains and the flexible 
threadlike tail comprising all collagenous regions plus 
the remaining non-collagenous domains.  
The height of the NC11 domain constituted 0,94 ± 0.06 
nm and the radius at half height (r0.5h) was calculated as 
9,48 ± 0,47 nm. The threadlike section of the remaining 
molecule C-terminal of the NC11 domain appeared to 
be a thin flat structure with a height between 0,5 and 
0,7 nm.  
Notably, at a distance of 94.8 ± 4.6 nm from the NC11 
terminus the molecular measurements increased either 
in height or diameter.  
The extension of this section contributed with 73,1 ± 
1,6 nm to the total length of the protein (figure 1D).  
Rotary shadowing images of purified recombinant 
collagen type XVI exhibited extended rod-like 
molecules with a globular domain at one end, probably 
constituting the large N-terminal NC11 domain (figure 
1E).  
The shape of the molecules revealed highly flexible 
regions, in some molecules even two or more kinks. 
The length of the molecules varied between 100-240 
nm, with the majority being close to 150 nm. 
The N-terminal half of human fibrillin-1/-2 binds dose-
dependent to collagen type XVI at low salt 
concentrations of 50-100 mM NaCl, while interaction 
between collagen type XVI and the C-terminal half of 
fibrillin-1/-2 under these conditions were considerably 
lower.  
These results indicate that monomeric fibrillin-1/-2 can 
interact with collagen type XVI with low affinity. Both, 
fibrillin-1 and fibrillin-2 did not interact with the 
recombinant NC11 domain. Soluble recombinant 
fibronectin interacted strongly with collagen type XVI 
at 150 mM NaCl with half maximal binding at ~12 
µg/ml (~55 nM fibronectin), indicating that fibronectin 
can bind to collagen XVI with high affinity (Kassner t 
al., 2004). 
Collagen XVI co-localizes with α2 integrin at the 
dermal epidermal junction (DEJ) (figure 2 A-C) and 
with α1 integrin and around fat cells in subdermal 
layers (figure 2 D-F). Cells bearing the integrins α1β1 
and α2β1 attach and spread on recombinant collagen 
type XVI. Collagen type XVI induces the recruitment 
of these integrins into focal adhesion plaques, a 
principal step in integrin signaling. In cell-free binding 
assays, collagen type XVI is more avidly bound by 
α1β1 integrin than by α2β1 integrin. Both integrins 
interact with collagen type XVI via the A-domain of
their α-subunits. A tryptic collagen type XVI fragment 
comprising the collagenous domains 1-3 is recognized 
by α1β1 integrin. Electron microscopy of complexes of 
α1β1 integrin with this tryptic collagen XVI fragment 
or with full-length collagen type XVI revealed a unique 
α1β1 integrin binding site within collagen type XVI 
located in the COL 1-3 domains (Eble et al., 2006). 
Expression 
Collagen type XVI is expressed in various cells and 
tissues. It is synthezised by dermal fibroblasts, smooth 
muscle cells (Grässel et al., 1996), dermal dendrocytes 
and dendritic cells in the skin (Akagi et al., 2002), 
articular and costal chondrocytes (Kassner et al., 2003), 
endometrial stromal cells (Tierney et al., 2003), basal 
dermal and oral keratinocytes (Grässel et al., 1999), 
bone marrow derived mesenchymal stem cells (Grässel 
et al., 2009), neurons from the dorsal root ganglio 
(Hubert et al., 2007), glioblastoma/astrocytoma cells 
(Senner et al., 2008) and intestinal myofibroblasts 
(Ratzinger et al., 2010).  
Collagen type XVI is further expressed in the limbal 
stem/progenitor niche which comprises clusters of cells 
in the basal epithelium. 
There it is associated with the corneal-limbal transition 
zone (Schlötzer-Schrehardt et al., 2007). 
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Figure 2. Distribution of collagen XVI and integrins α1β1 and α2β1 in adult murine skin. Cryosections from murine skin were 
stained with purified anti-collagen XVI-antibodies (red fluorescence, A, B, D, E), and with mAb JA221 directed against the integrin α2 
subunit (green fluorescence, A, C) and with mAb AGF-1 directed against the integrin α1 subunit (green fluorescence, D, F), Panels A and 
D show combined staining for collagen XVI and the integrin subunits. The same sections are shown either in panel B, E stained for 
collagen XVI together with DAPI, or in panel C, F stained for integrin subunits and DAPI. E= epidermis, F= fatty tissue, D= dermis, DEJ= 
dermal epidermal junction zone. All pictures were taken at 400 x magnification. 
 
Figure 3. Ultrastructural localization of collagen XVI in fibrillar extracts from skin and cartilage by immunogold electron 
microscopy. Double labeling of collagen XVI (18 nm gold particles, light arrow) and fibrillin-1 (12 nm gold particles, dark arrow) 
demonstrate co-localization on "bead on the string" microfibrils with collagen XVI bound at one distinct bead of the microfibrils. The large 
D-periodically banded collagen I fibrils lack collagen XVI labeling (light arrowhead). Bar= 0,12 µm. (A). In cartilage a special 
subpopulation of thin D-periodically banded cartilage fibrils were labeled with collagen XVI (black arrow, 18 nm gold particles), other fibril 
populations lack collagen XVI association, Bar= 0,09 µm. (B). 
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During early mouse development, collagen type XVI 
occurs in many tissues and is co-distributed with the
major fibrillar collagens. In particular, it is strongly 
expressed in differentiating chondrocytes and dermal 
fibroblasts, smooth muscle cells of the heart and dorsal 
root neural fibers, whereas in adult mice no signal 
appears in brain tissue. Additional expression is found 
in the cortical areas of the kidney and ovaries (Lai and 
Chu, 1996). In adults it is found in skin, cartilage, 
gastrointestinal tract and glioma tissues. 
Localisation 
Extracellular matrix of tissues. For skin and cartil ge 
tissue its suprastructure is known. It is associated to the 
fibrillin containing microfibrillar apparatus in the 
dermal-epidermal junction zone in skin and to collagen 
II containing D-banded cartilage fibrils in costal 
cartilage (Grässel et al., 1999; Kassner et al., 2003). It 
is depositred pericellular around fibroblasts and smooth 
muscle cells (Grässel et al., 1996) and in the territorial 
region of chondrocytes (Kassner et al., 2003). 
Function 
Morphogenesis and assembly of distinct 
suprastructures in different tissues, i.e. microfibrillar 
apparatus in the dermis and fibrillar networks in 
various connective tissues (figure 3A, B). Presumably, 
it is an adaptor protein such as collagen type IX and
connects and organizes large fibrillar networks and thus 
regulates integrity and stability of ECM (Eble et al., 
2006; Grässel et al., 1999; Kassner et al., 2003). It is a 
substrate for adhesion and invasion of tumor cells, i.e. 
glioblastomas (Senner et al., 2008) and regeneration of 
connective tissues after neural injury (Hubert et al.,
2007). In addition, it induces invasiveness of 
glioblastoma by altering the cell-matrix interaction 
(Bauer et al., 2011) and proliferative activity of ral 
squamous cell carcinoma by altering the cell cycle 
activity of the tumor cells (Ratzinger et al., 2011). 
Notably, COL16A1 is a Smad-signalling specific target 
gene for BMP-4/-6 in hepatocellular carcinoma where 
these BMPs are involved in the process of 
carcinogenesis (Maegdefrau and Bosserhoff, 2012). 
Homology 
Based on conserved structural features with other 
FACIT-collagens, namely: collagens type IX, type XII, 
type XIV, type XIX, type XX, type XXI and type 
XXII.  
These structural features are:  
1. The presence of two highly conserved cysteine 
residues separated by four amino acids at the NC1-
junctions and the existence of two G-X-Y triplet 
imperfections within the COL2 domain.  
2. A succession of triple-helical domains connected by 
short non-collagenous domains and the presence of a 
large N-terminal domain that always exhibits a TSPN 
subdomain next to the collagenous domain. 3. Besides 
from these common criteria, the FACITs display 
remarkable divergence in the size and composition of 
their N-terminal domains and in the number of their 




There are no reports about mutations in the COL16A1 
gene published as yet. 
Germinal 
None yet described. 
Somatic 




The progression of glioblastoma growth is 
characterized by diffuse invasion of tumor cells into the 
brain tissue. COL16A1 was upregulated on mRNA 
level in glioblastoma tissues compared to normal cortex 
(figure 4). Collagen type XVI protein was detected in 
glioblastoma tissue and was secreted by glioblastoma 
cell lines. A siRNA mediated knockdown of collagen 
type XVI resulted in decreased cell adhesion of 
glioblastoma cell lines whereas adhesion was 
augmented on culture surfaces coated with recombinant 
collagen type XVI. However, the migration potential of 
glioblastoma cells on collagen type XVI remained 
unaffected. Collagen type XVI appears to play a 
supportive role for tumour specific remodelling of 
extracellular matrix indicated through de novo 
expression by glioblastoma cells (Senner et al., 2008).  
Novel data suggest that in glioblastoma tissue collagen 
XVI may impair the cell-cell interaction in favour of 
enhancement of invasion.  
The modification of the β1-integrin activation pattern 
through collagen XVI might be a molecular mechanism 
to further augment the invasive phenotype of glioma 
cells (Bauer et al., 2011). 
Disease 
Gliomas are the most frequent intrinsic brain tumors 
and comprise astrocytic gliomas (grades II, III, IV) 
including fibrillar astrocytoma (WHO grade II), 
anaplastic astrocytoma (WHO grade III), and 
glioblastoma (WHO grade IV).  
They are characterized by diffuse invasion of tumour 
cells into the brain parenchyma.  
The fatal outcome of this disease results from single-
tumour cells that have already invaded distant brain 
regions at the time of diagnosis.  
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Figure 4. Immunohistochemical staining of collagen type XVI and collagen type IV in brain sections. Immunofluorescence staining 
on cryo-sections for collagen XVI (red, white arrows) and collagen IV (green, light blue arrow heads) reveals an expression of collagen 
XVI around blood vessels, however not in the parenchyma of normal brain (A), whereas in glioblastoma (B) and pilocystic astrocytoma 
(C) collagen XVI is highly expressed throughout the tumour tissue. 
 
Glioblastoma behave highly invasive which cause the 
high morbidity and mortality rates of these tumours 
(Claes et al., 2007; Louis et al., 2007). 
Prognosis 
The 5-year survival rate of glioblastoma (WHO grade 
IV) is 3%. 
Oral squamous cell carcinoma 
tumorigenesis 
Note 
There is still a lack of reliable prognostic tools for oral 
squamous cell carcinoma (OSCC).  
Initial, early stages of the tumor are hard to identify. 
COL16A1 expression is upregulated in dysplastic 
stages of OSCC compared to normal oral epithelium 
where it is restricted to the dermal-epidermal junction 
(figure 5).  
Moreover, in protein lysates from OSCC tissues more 
collagen type XVI was detected by immunoblotting 
compared to lysates from normal oral tissue.  
Overexpression of collagen type XVI in an OSCC cell
line (PCI13) led to an upregulation of kindlin-1 and an 
increased interaction of kindlin-1 with beta1-integrin.  
Beta1-integrin activity was enhanced in collagen type 
XVI overexpressing OSCC cells and an earlier S-phase 
and G2/M-phase entry six hours after synchronisation 
was observed compared to control cells leading to a
markedly higher proliferation activity.  
Blocking beta1-integrin induced a decrease of the 
proliferative activity of the collagen XVI 
overexpressing cells (Ratzinger et al., 2011).  
In summary, collagen type XVI overexpression leads to 
early S-phase entry in OSCC cells due to enhanced 
interaction of kindlin-1/beta1-integrin and subsequnt 
beta1-integrin activation. 
Disease 
Head and neck cancer is the sixth leading cancer by 
incidence worldwide (Rousseau and Badoual, 2011) 
and affects more than 500000 people each year. Oral 
squamous cell carcinoma represents 95% of all head 
and neck cancer forms and within the past ten years its 
incidence has increased more than 50%. Despite 
multimodal therapies including excision of malignant 
tissue and a combination of radio- and chemotherapy 
the 5-year survival rate is still only 53%.  
A high rate of patients remains with a poor response to 
therapy and high frequencies of relapses (Bettendorf et 
al., 2004). Moreover, frequent lymph node metastasi 
involving migration and invasion of aberrant cells from 
the primary neoplasm to distant sites results in poor 
prognosis (Bray et al., 2002; Parkin et al., 2005). 
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Figure 5. Immunohistochemical staining of collagen type XVI in dysplastic areas of tissue from oral squamous cell carcinoma. 
Immunofluorescence staining on paraffin-sections for collagen type XVI (red) reveals a strong and diffuse expression of collagen type 
XVI throughout the oral epithelium in contrast to normal oral epithelium where collagen type XVI location is restricted to the dermal-
epidermal junction. BM= basal membrane, EP= oral epithelium, SL= surface layer, SM= submucosa. 
 
Prognosis 
The 5-year survival rate of head and neck squamous 
cell carcinoma is 40-50%. 
Crohn's disease 
Note 
Collagen type XVI is produced by myofibroblasts in 
the normal intestine and its synthesis is increased in the 
inflamed bowel wall (figure 6).  
Collagen type XVI promotes cell spreading, formation 
and maturation of focal adhesion contacts. 
Myofibroblasts develop increased numbers of focal 
adhesion contacts on collagen type XVI with increased 
recruitment of α1 integrin into the focal adhesions at 
the tip of the cells. Focal adhesions on myofibroblasts 
from inflamed colon tissue also display an increase in 
length on collagen type XVI compared to collagen type 
I.  
As a result, larger forces can be transmitted which then 
promote and augment contraction of the ECM and 
ultimately result in elevated stricture formation. 
Increased cell spreading on collagen type XVI 
presumably adds to the maintenance of cells in the 
inflamed intestinal regions and thus promotes fibrot c 
responses of the tissue and prolongs further 
disturbances of the delicate homeostasis between cells 
and surrounding ECM (Ratzinger et al., 2010). 
Disease 
Crohn's disease is characterized by chronic 
inflammation of the gastrointestinal tract, accompanied 
by other systemic abnormalities. Inflammatory lesion  
progress to intestinal fibrotic processes.  
A pathologically overshooting healing response to 
inflammation-induced disintegration of mucosal tissue 
leads to excessive tissue repair. 
An altered cyto-architecture of the bowel wall with 
disruption of the muscularis mucosa, thickening of the
muscularis propria, and deposition of collagens 
contributes to the inflammation process (Burke et al., 
2007).  
Fibrillar and non-fibrillar collagens are up-regulated in 
CD (type I, II, IV, V, VI) (Graham et al., 1988; Matthes 
et al., 1992; Pucilowska et al., 2000; Stallmach et al., 
1992).  
Mesenchymal cells like fibroblasts, myofibroblasts and 
smooth-muscle cells are the main producers of 
extracellular matrix components and play an important 
part in tissue growth and development (Powell et al., 
1999; Simon-Assmann et al., 1995).  
Myofibroblasts are considered as central player in 
tissue repair contributing to fibrosis, stricture formation 
and stenosis by reconstituting a collagen-rich 
extracellular matrix (ECM) and promoting wound 
closure by contraction (Pucilowska et al., 2000; 
Tomasek et al., 2002).  
Myofibroblasts motility, their ability to contract 
wounds and the production of ECM is altered in 
chronic inflammation.  
Normal wound healing would terminate the contractile 
and synthesizing activity of myofibroblasts by 
apoptotic reduction of the cell number (Desmoulière et 
al., 1995). 
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Figure 6. Morphological distribution of collagen type XVI in healthy and diseased intestine. Morphological distribution of collagen 
XVI (green fluorescence) and a-smooth muscle actin (red fluorescence) is demonstrated for the bowel wall of healthy tissue (A-D) and 
CD tissue (E-H). Arrow heads indicate positive staining for collagen XVI. A negative control is displayed as inlet in D. c: crypts, m: muscle 
layer, s: submucosa, bv: blood vessel, e: erythrocytes, ep: epithelial cells, lp: lamina propria. 
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Neuronal development and regeneration 
Note 
In the nervous system, low collagen type XVI 
expression was reported in the brain, however, in spi al 
root fibres high gene expression levels were detectd 
during development (Lai et al., 1996). A SAGE banks 
analysis showed an induction of Col16a1 gene 
expression during development and after nerve injury 
in dorsal root ganglia (DRG) of mice which contain the 
cell bodies of neurons (Méchaly et al., 2006). Their 
axons transmit sensory information from the periphery 
to the central nervous system. During development and 
regeneration, neurites require extracellular matrix for 
growth and guidance (Hari et al., 2004), however, the 
composition of the ECM is yet unknown. In cell 
culture, satellite cells express collagen type XVI 
indicating secretion and deposition by neuronal and 
glia cells. Collagen type XVI participates in final steps 
of DRG structural and functional maturation. So far, 
collagen type XVI is the only FACIT collagen, whose 
expression is regulated by nerve injury, taking 
presumably part in remodelling events like 
inflammation, cell proliferation, and neuronal death 
(Hubert et al., 2007). 
Fibrotic skin diseases 
Note 
In skin, COL16A1 transcripts were detected in cultured 
dermal fibroblasts and keratinocytes (Pan et al., 1992). 
Gene expression in fibroblasts varied according to the 
horizontal layers in skin. Fibroblasts explanted from the 
upper dermis displayed higher COL16A1 gene 
expression than those from the middle and lower 
dermis. In cultured skin fibroblasts an increase of 
COL16A1 mRNA level was observed in stationary 
phases of the cell cycle (non-adherent and confluent 
phases) (Tajima et al., 2000). In localized sclerodma 
and in systemic scleroderma COL16A1 gene 
expression was upregulated 2,3 fold and 3,6 fold, 
respectively, compared with keloid and normal contrls 
(Akagi et al., 1999). 
Disease 
Systemic and localized scleroderma are characterized 
by systemic and localized deposition of highly 
overproduced collagens in the skin. This collagen 
accumulation is a result of overproduction of collagens 
type I, II, and VI (Graves et al., 1983; Krieg et al., 
1985). 
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